Table 3: Fold Change expression in Wound Healing and Nfkb Target Genes following Oral E-IBU and L-IBU dosing.
Wound Healing | Nfkb Targets | ||||
Fold Change# | Fold Change# | ||||
Gene‡ | E-IBU | L-IBU | Gene‡ | E-IBU | L-IBU |
Cxcl5 | 28.4* | 3.49* | Il6 | 7.84* | 3.17 |
Col3a1 | 10.02* | 2.27* | Il1rn | 6.81* | 3.92* |
Mmp9 | 7.34* | 45.01* | Cxcl3 | 6.11* | 2.56 |
Col5a1 | 6.9* | 4.32* | Ptgs2 | 5.95* | 4.07* |
Wisp1 | 5.69* | 1.45 | Ccl5 | 5.84* | 3.41* |
Col1a1 | 5.16* | 1.39 | Cxcl10 | 5.58* | 2.73* |
Col5a2 | 4.99* | 3.68* | Relb | 4.33* | 2.35 |
Serpine1 | 4.72* | 1.66 | F8 | 4.1* | 1.69 |
Timp1 | 3.91* | 1.29 | Rel | 4.09* | 2.01 |
Col1a2 | 3.83* | 1.07 | Cxcl9 | 3.78* | 1.32 |
Col5a3 | 3.44* | 1.66 | Lta | 3.46* | 3.54 |
Cdh1 | 3.37* | -1.31 | Il12b | 3.26* | 2* |
Plat | 3.19* | 1.58 | Ltb | 3.23* | 2.08 |
Ccl12 | 3.17* | 1.15 | Ccr5 | 3.2* | 2.92* |
Hgf | 3.05* | 1.44 | Ccl12 | 2.92* | 1.76 |
Itga4 | 3.01* | 1.11 | Bcl2a1a | 2.83* | 1.53 |
Stat3 | 2.75* | 2.27 | Cdkn1a | 2.46* | 1.8 |
Itga5 | 2.61* | 1.16 | Ccl22 | 2.34* | -1.09 |
Vegfa | 2.49* | 1.99 | Selp | 2.27* | 2.98* |
Ctsk | 2.47* | 1.8 | Tnf | 2.21* | 1.32 |
Mif | 2.22* | 1.53 | Rela | 2.07* | 1.98* |
Col4a1 | 1.96* | 1.27 | Sele | 2.06* | 1.54 |
Rhoa | 1.62* | 1.65* | Gadd45b | 1.98* | 1.21 |
Cd40lg | 1.11 | 3.99* | Cd80 | 1.84* | 1.59* |
Plg | -3.80* | -1.98 | Il1b | 1.76* | -2.7 |
Nfkbia | 1.64* | 1.51* | |||
Ifng | 1.11 | 2.47 | |||
Csf3 | 1.07 | 4.25* |
‡Genes are organized from highest to lowest fold activation; #Statistical analyses was performed for comparison with 25 d No Drug groups and * indicates p < 0.05.